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Among the factors that would explain the distribution of mitochondrial lineages in europe, climate 
and diseases may have played an important role. A possible explanation lies in the nature of the 
mitochondrion, in which the energy generation process produces reactive oxygen species that 
may influence the development of different diseases. The present study is focused on the medieval 
necropolis of San Miguel de Ereñozar (13th–16th centuries, Basque country), whose inhabitants 
presented a high prevalence of rheumatic diseases and lived during the Little ice Age (LiA). our results 
indicate a close relationship between rheumatic diseases and mitochondrial haplogroup H, and 
specifically between spondyloarthropathies and sub-haplogroup H2. One possible explanation may be 
the climate change that took place in the LiA that favoured those haplogroups that were more energy-
efficient, such as haplogroup H, to endure lower temperatures and food shortage. However, it had a 
biological trade-off: the increased risk of developing rheumatic diseases.
Various pieces of evidence suggest that mitochondrial dysfunction could influence the pathogeny of some human 
diseases, including neurodegenerative disorders1, metabolic diseases2, rheumatic pathologies3,4, processes associ-
ated to age5 and cancer6. A possible explanation lies in the functionality of the mitochondrion, which is a cellular 
organelle responsible for supplying most of the energy required for cellular activity, turning nutritional molecules 
into ATP through oxidative phosphorylation7. Mitochondrial metabolism produces Reactive Oxygen Species 
(ROS) and reactive metabolic intermediates, which are signals that transmit information between the mitochon-
drion and the nucleus8,9, and they can modify the expression of nuclear genes, altering numerous cellular pro-
cesses and metabolic routes that may influence the development of different diseases10.
The present study is focused on the analysis of rheumatic diseases and the role of mitochondrial lineages in 
their development and prevalence, given the associations provided by previous works3,4. It has been observed that 
mitochondrial function is altered in chondrocytes of individuals with osteoarthritis (OA)3,4, producing oxidative 
stress and increasing chondrocyte apoptosis and cartilage degradation4,11,12.
To date, some studies have analysed the relationship between mitochondrial haplogroups and rheumatic 
diseases. It has been stated that haplogroups H and U are significantly related to a higher risk of developing 
degenerative bone diseases and with greater severity13–18, whereas haplogroups J and T are significantly related 
to a decrease in the incidence and progression of OA13–15,17,19–21, with haplogroup J being also associated with 
psoriatic arthritis (PsA)22. However, no significant association has been found between European mitochondrial 
haplogroups and rheumatoid arthritis (RA)18.
The role of haplogroup H in the pathogenesis of rheumatic diseases is due to the fact that, as it shows a high 
energy efficiency, it generates a greater oxidative stress, increasing the production of ROS, which causes the degra-
dation of the cartilage and the risk of developing degenerative bone diseases13–18. On the other hand, the possible 
protective effect described for haplogroups T and J lies in a lower energy efficiency in the process of converting 
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calories into ATP, which generates a lower production of ROS and a lower oxidative damage. This mechanism 
protects the cell from apoptosis and decreases the degeneration of the cartilage involved in the pathogenesis of 
OA23,24. It has been suggested that the differential association of some mitochondrial haplogroups with rheu-
matic pathologies could be related to an adaptation process of Homo sapiens to cold climates, when this species 
migrated out of Africa25–27. Haplogroup H is currently the most common and diverse mitochondrial lineage in 
Europe (55–40%), which originated 25,000–30,000 years ago in Southwest Asia and entered Europe from the 
Near East before the Last Glacial Maximum (LGM) (~22,000 years)28–32. Haplogroup U, present in 11% of current 
Europeans, is the oldest maternal lineage in Europe and emerged in Southwest Asia around 55,000 years ago from 
where it expanded to Europe28,32–34. Both haplogroups subsisted in the glacial refugia of Southwestern Europe 
during the LGM, after which they re-expanded, thus their frequencies were molded by different demographic 
and cultural factors. Some mitochondrial variants, which were critical for human adaptation in different environ-
ments, could have favoured the survival and reproduction of populations that lived in particular climate areas, 
whereas in other regions they may have not been adaptative35.
Given the high prevalence of rheumatic diseases found in the medieval necropolis of San Miguel de Ereñozar 
(Ereño, Bizkaia, Spain, 13th–16th centuries), in the present study we analyse the possible relationship between these 
diseases and the different mitochondrial lineages, considering the influence of the Earth’s temperature decrease during 
the Little Ice Age (14th–19th centuries). During this period, there was a marked temperature decrease in the Northern 
Hemisphere, which had negative consequences for survival36, since the European glaciers advanced in the mountain 
valleys and the rainfall and floods increased, which caused bad harvests, famine, conflict, epidemics and increased 
mortality37–40. We believe that these conditions could have influenced the energy production process of mitochondria, 
promoting mitochondrial dysfunction and the development of different rheumatic diseases.
Materials
In the present study, we analysed the human bone remains of 163 individuals recovered from the medieval site of 
San Miguel de Ereñozar (13th–16th centuries). This necropolis is located in the northeast of the province of Bizkaia 
(Basque Country, Spain), in the region of Busturialdea-Urdaibai, which is composed of small urban nuclei; the 
studied necropolis is in one of these urban nuclei.
A total of 47 out of 163 individuals recovered from the necropolis presented rheumatic manifestations. For 
comparative purposes, another control group of 43 individuals was selected according to the following criteria: 
(1) adult (>45 years), (2) absence of rheumatic bone manifestations, and (3) well-preserved remains to allow the 
molecular analysis.
Since this study is focused on rheumatic pathologies, two differentiated groups were established: (1) individ-
uals without pathological bone manifestations (N = 43), and (2) individuals who showed pathological joint man-
ifestations (N = 47), with diagnoses of entities such as SpA, OA and RA; in few cases it was not possible to reach 
an accurate diagnosis of the rheumatic disease due to the scarcity of the preserved bone remains. To perform the 
DNA extraction of these 90 individuals, dental pieces were preferably selected, since these provide better results 
than bones when recovering DNA41,42. Only in the cases where no dental pieces were preserved, compact bones 
were selected, preferentially ribs, as this is the anatomic region with the lowest anthropological interest.
Methods
The diagnosis of rheumatic diseases carried out in the 163 individuals recovered from the site of San Miguel de Ereñozar 
was described in Laza et al.43, following the protocol proposed by Ventades et al.44. The process of DNA extraction was 
conducted according to the procedure described in Hervella et al.45,46 and Laza et al.47. Mitochondrial DNA D-loop 
hypervariable segment I was sequenced from the aDNA extracts by amplifying six overlapping fragments, each with 
an approximate length of 100 bp, which finally provided the sequencing between nucleotides 15,995 and 16,39948. In 
the cases in which individuals presented the revised Cambridge Reference Sequence (rCRS) haplotype, a fragment 
(7F/7R) of mtDNA D-loop Hypervariable Segment II was sequenced, which contains position 7345,46. In those indi-
viduals who carried polymorphism A073G, PCR-RFLPs were conducted with AluI restriction enzyme to determine 
the nucleotide in position 7025, with the aim of verifying whether this sequence corresponded to haplogroup H. The 
mtDNA sequences obtained were aligned with the BioEdit software and then filtered using the databases Haplogrep 
(https://haplogrep.uibk.ac.at) and Phylotree (https://www.phylotree.org), in order to determine the haplogroup, 
sub-haplogroup and mitochondrial haplotype of the analysed samples49,50.
The following were some of the authentication criteria applied in this study: (1) controls of DNA extraction 
and amplification (extraction blank and negative control of the PCR), (2) fluorimetric quantification (QUBIT) of 
the number of template DNA molecules recovered from the extracts obtained, validating the reproducibility of 
the results, and (3) replication of the results by independent researchers at different times51–53.
For the data analysis, several principal component analyses (PCAs) were conducted using the SPSS Statistics 
v24 software, with the aim of interpreting the covariation of the bone pathologies and mitochondrial lineages in 
the analysed individuals. The Fst distance and the genetic diversity of different groups were calculated taking into 
account the frequencies of mtDNA haplogroups and sub-haplogroups using Arlequin 3.5.2.2.
Results
The analysis of mtDNA in 90 adult individuals of the Ereño necropolis allowed identifying 7 different mito-
chondrial haplogroups (H, U, T, K, R, J, HV) (Table 1). The most frequent haplogroup was H (73.3%), which 
is also the most frequent haplogroup in the current population of Europe (55–40%) and in the region of 
Busturialdea-Urdaibai, where the Ereño necropolis is located28,30,31,54–56. The Ereño necropolis shows higher fre-
quencies than the region of Busturialdea-Urdaibai for haplogroups T and R, and lower frequencies for HV, J and 
U; the frequencies for haplogroup K are similar in both populations (Table 1)56. The differences between the two 
populations were statistically significant (pvalue = 0.02).
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In the present study, 18 mitochondrial sub-haplogroups were defined in the Ereño necropolis. The most fre-
quent sub-haplogroup is H2 (36.7%), followed by sub-haplogroups H1, H3 and T2 (Table 2); all of them have 
higher frequencies in the analysed necropolis with respect to the current population of Busturialdea-Urdaibai56. 
However, other sub-haplogroups, such as U5, J1 and HV, show lower frequencies in the studied necropolis than 
in the current population of Busturialdea-Urdaibai (Table 2)56, with significant differences between the two pop-
ulations ( pvalue = 0.045).
The analysis of the mitochondrial haplotypes allowed identifying the presence of 55 different haplotypes in 
the 90 individuals analysed from the medieval necropolis of Ereño, which demonstrates the high variability of the 
population of this site (Supplementary Table S1).
Regarding the rheumatic pathologies of the 90 adult individuals of the Ereño necropolis, 47 of them (52.2%) 
had some type of joint pathology and 43 (47.7%) did not have any pathological bone manifestations. Of the 7 
mitochondrial haplogroups identified (H, HV, J, K, R, T, U), 5 were found in the individuals with rheumatic 
pathologies (H, J, R, T, U), whereas all 7 haplogroups were identified in the individuals without bone pathologies, 
with the absence of haplogroups HV and K in the first group (Supplementary Fig. S1). The individuals with rheu-
matic pathologies showed a lower diversity of mitochondrial haplogroups (0.3691) compared to the individuals 
without rheumatic pathologies (0.5360), although no statistically significant differences were found between the 
two groups ( pvalue = 0.23).
Haplogroups
% Ereño necropolis 
(N = 90)
% Busturialdea-Urdaibai 
(N = 158)
H 73.3 55.1
U 10.0 15.2
T 6.7 4.4
K 3.3 3.2
R 3.3 —
J 2.2 10.1
HV 1.1 7.0
X — 3.2
I — 1.3
W — 0.6
Table 1. Frequency of mitochondrial haplogroups in the medieval necropolis analysed in the present study 
(Ereño, 13th–16th centuries) and in the current population where the Ereño necropolis is located, i.e., the region 
of Busturialdea-Urdaibai (Bizkaia, Spain)56.
Sub-haplogroups
% Ereño necropolis 
(N = 90)
% Busturialdea-
Urdaibai (N = 158)
H2 36.67 31.65
H1 21.11 16.46
H3 6.67 3.16
T2 6.67 3.80
U5 5.56 12.66
H14 3.33 —
K* (K1, K2) 3.33 3.2
R8 3.33 —
H5 2.22 1.27
J1 2.22 8.86
U* 2.22 —
H7 1.11 —
H11 1.11 —
H24 1.11 —
HV* 1.11 10.6
U1 1.11 —
U3 1.11 —
X* — 3.2
I* — 1.3
W* — 0.6
Table 2. Frequency of the mitochondrial sub-haplogroups in the medieval necropolis analysed in the present 
study (Ereño, 13th–16th centuries) and in the current population where the Ereño necropolis is located, i.e., the 
region of Busturialdea-Urdaibai (Bizkaia, Spain)56.
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The results of the mitochondrial haplogroups regarding joint pathologies show that 56.1% of the individuals 
who carried haplogroup H had joint lesions, whereas the rest of the individuals (43.9%) did not have signs of 
arthropathy (Supplementary Fig. S1). Although the other 6 haplogroups had a much lower frequency than hap-
logroup H, it is worth mentioning that, in the case of haplogroup U (10%) (Table 1), it was observed that 66.7% 
of the individuals had rheumatic lesions, whereas 33.3% showed no joint bone lesions (Supplementary Fig. S1). 
Regarding haplogroup T (6.7%) (Table 1), lower frequency values were obtained in the individuals with joint 
bone pathologies (33.3%) (Supplementary Fig. S1). Haplogroups K, R, J and HV had a very low frequency in this 
population (<5%); in fact, haplogroups K and HV were not found in individuals with rheumatic pathologies 
(Table 1, Supplementary Fig. S1).
In order to obtain a more global view of the variability of the individuals of the Ereño necropolis (N = 90), a 
PCA was conducted considering the mitochondrial haplogroups of both groups, i.e., individuals diagnosed with 
joint pathologies (N = 47) and without joint pathologies (N = 43), which generated two principal components 
that explained 82.2% of the variance (Fig. 1A). In PCA axis 1 (50.7% of the variance), the variables with the high-
est correlation values were: joint pathology (Pathology, −0.906) and absence of joint pathology (Non-Pathology, 
0.906). In the second component (31.5% of the variance), the variables with the highest correlation values were: 
haplogroup H (H, −0.859) and haplogroup U (U, 0.703).
Figure 1. Principal component analysis of the frequency of the mitochondrial haplogroups and the variables 
pathology and non-pathology of the 90 individuals recovered from the medieval necropolis of San Miguel de 
Ereñozar (Ereño, Bizkaia, Spain, 13th–16th centuries). (A) Distribution of the variables pathology and non-
pathology and the mitochondrial haplogroups. (B) Distribution of the individuals according to the variables 
pathology and non-pathology and the mitochondrial haplogroups. Component 1: 50.7% of the variance; 
component 2: 31.5% of the variance.
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When representing the individuals on the two principal components of the PCA (Fig. 1B), we found that 
in the most positive end of component 1 there is a group characterised for having rheumatic pathologies and 
carrying haplogroup H. In the most positive end of the second component of the PCA there are the individuals 
who had no rheumatic lesions, and in the most negative end there are the individuals that did show joint lesions, 
regardless of the mitochondrial haplogroup carried by any of these two groups. Considering the 2 axes of the 
PCA, it is worth highlighting that the most differentiated individuals were those who had rheumatic pathologies 
and carried haplogroup H, which indicates that haplogroup H would be more related to those individuals who 
had a joint pathology. Therefore, the next step was to analyse the distribution of the haplogroups in the indi-
viduals who had a particular rheumatic disease (spondyloarthropathy, osteoarthritis, rheumatoid arthritis and 
rheumatic pathology without an accurate diagnosis).
When analysing the mitochondrial variability only in the individuals with rheumatic diseases (N = 47), 5 
different haplogroups were identified (H, U, T, R, J), with H being the most frequent one, followed by U; the rest 
of the haplogroups (T, R, J) showed frequency values below 5%. With respect to the type of rheumatic disease, in 
the present study it was observed that almost half of the individuals with haplogroup H had spondyloarthropa-
thies (SpA), whereas the other 4 haplogroups represented a small sample size which did not allow any statistical 
valuation (Supplementary Fig. S2).
A second PCA was carried out in order to analyse the variability of the mitochondrial haplogroups only in the 
individuals who had rheumatic diseases, which produced two principal components that explained a variance 
of 73.2% (Fig. 2). The variables with the highest correlation values in PCA axis 1 (47.8% of the variance) were 
Figure 2. Principal component analysis of the 90 individuals recovered from the medieval necropolis of San 
Miguel de Ereñozar (Ereño, Bizkaia, 13th–16th centuries). (A) Distribution of the variables: rheumatic diseases 
and mitochondrial haplogroups. (B) Distribution of the individuals according to the rheumatic diseases and 
mitochondrial haplogroups they showed in each case. Component 1: 47.8% of the variance; component 2: 25.4% 
of the variance.
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haplogroup H (H, −0.811) and haplogroup U (U, 0.724), and in PCA axis 2 (25.4% of the variance), the varia-
bles with the highest correlation values were osteoarthritis (OA, −0.776) and spondyloarthropathy (SpA, 0.770) 
(Fig. 2A).
When representing the individuals on the two principal components (Fig. 2B), we found the individuals who had 
SpA and haplogroup H in the most positive end of axis 1. In axis 2, the individuals with OA were in the most positive 
end and in the most negative end there were those diagnosed with SpA, with both groups carrying different mitochon-
drial haplogroups. Considering the PCA axes, it is worth highlighting that the most differentiated individuals were 
those with SpA and haplogroup H, which indicates the covariance of haplogroup H and SpA.
18 different mitochondrial sub-haplogroups were identified in this study (H2, H1, H3, T2, U5, H14, R8, H5, 
J1, K1, U*, H7, H11, H24, HV*, K2, U1, U3) (Table 2), 8 of which were shared by individuals with and without 
rheumatic pathologies (H2, H1, H3, T2, U5, H14, R8, J1) (Supplementary Fig. S3).
The most frequent mitochondrial sub-haplogroup found in this necropolis was H2 (36.7%) (Table 2), in 
which 66.7% of the individuals showed joint lesions (Supplementary Fig. S3). The rest of the mitochondrial 
sub-haplogroups showed low frequency values, preventing any statistical valuation (Table 2, Supplementary 
Fig. S3). When we analysed the distribution of the mitochondrial sub-haplogroups in the different rheumatic 
diseases, we found that the most frequent sub-haplogroup (H2) appeared in 57% of the individuals with SpA, a 
very high frequency compared to other rheumatic pathologies (Supplementary Fig. S4).
Discussion
The genetic heritage of the current European populations is the result of numerous demographic and cultural 
episodes that took place since the arrival of the anatomically modern Homo sapiens to Europe around 45,000 
years ago57. Regarding the mitochondrial lineages, haplogroup H is the most common and diverse in the current 
European population (55–40%)28,30,31,54, and haplogroup U is the oldest European lineage, with a current fre-
quency of 11%28,32–34. Both lineages survived in the glacial refugia of Southwestern Europe during the Last Glacial 
Maximum (LGM)29–32, from where they re-expanded to Northern and Eastern Europe.
Among the causes that would explain the distribution of haplogroup H in the current European population, 
the climate change that took place during the LGM seems to have played an important role. Moreover, it has been 
described that the demographic changes that occurred during the Neolithic were a key factor for the diversifica-
tion of haplogroup H and for the increase of its frequency, becoming the main haplogroup at present in Western 
Europe (55–40%)28,30,31,58. The highest frequency has been reported in the populations of the Northern Iberian 
Peninsula (Basque Country, Asturias and Galicia), decreasing toward Northern and Eastern Europe, with the 
exception of Wales, where this haplogroup has a frequency of over 50%54,55.
Furthermore, some authors have suggested the existence of a relationship between mitochondrial DNA 
(mtDNA) and rheumatic diseases, based on the critical role that the mitochondrion plays in cellular function 
and in survival against oxidative stress59,60. In the energy generation process, via oxidative phosphorylation, the 
mitochondrion produces Reactive Oxygen Species (ROS), whose increase causes damage to lipids, proteins and 
DNA, promoting mitochondrial dysfunction and inflammation in different pathologies11,59,61,62.
Different studies have shown that some mitochondrial haplogroups can increase the risk of developing degen-
erative joint diseases, whereas other haplogroups constitute a protection factor19,59,63–67. Haplogroup H could be 
related to a higher risk of developing degenerative bone diseases13–18, whereas other haplogroups, such as J and T, 
would be associated to a lower risk of developing osteoarthritis (OA) and psoriatic arthritis13–15,17,19–21.
In this context, the population recovered from the medieval necropolis of San Miguel de Ereñozar (Ereño, 
Bizkaia, Basque Country, Spain, 13th–16th centuries), allowed us to evaluate the possible relationship between 
mtDNA and rheumatic diseases, since this population presents three relevant characteristics: (i) a high frequency 
of mitochondrial haplogroup H, (ii) a chronology that overlaps with an unfavourable climate period (Little Ice 
Age, LIA; 14th–19th centuries), and (iii) a high prevalence of rheumatic diseases (30%), which were diagnosed as 
spondyloarthropathies (SpA) (45%), osteoarthritis (OA) (36%) and rheumatoid arthritis (RA) (4%), with a 15% 
frequency of rheumatic pathologies that could not be accurately diagnosed.
In the present study, we analysed the mitochondrial variability of 90 adult individuals of the medieval necrop-
olis of Ereño, finding 7 haplogroups (H, U, T, K, R, J and HV) and 18 different sub-haplogroups (Tables 1 and 2). 
The most frequent mitochondrial haplogroup was H (73.3%), whose frequency is higher than that reported in 
the current population of Busturialdea-Urdaibai (Table 1)56. These two populations showed statistical significant 
differences due to the high frequency of haplogroup H in the necropolis of Ereño.
The analysis of the mitochondrial haplogroups revealed the existence of 55 different haplotypes among the 90 
individuals, with haplotype rCRS presenting a very high frequency in the necropolis (≃24%) (Table S1), although 
similar to the values found in the current populations of the Basque Country (27-21%)55,56. Therefore, we can 
discard the existence of endogamy among the individuals of the necropolis.
When analysing the relationship between haplogroup H and rheumatic diseases, it was observed in the pres-
ent study that 56% of the individuals that carried this haplogroup had rheumatic lesions, compared to 44% of 
the individuals who did not show these bone pathologies, which suggests that carrying haplogroup H can pose 
a greater risk of developing rheumatic diseases (Supplementary Fig. S1). This relationship would be supported 
by the hypothesis that haplogroup H would be related to a greater oxidative stress, greater cartilage degradation 
and higher risk of developing degenerative bone pathologies13–18. In the present study, it was observed that hap-
logroup H was more frequent among the individuals who had bone manifestations characteristic of SpA (81%) 
(Supplementary Fig. S2, Fig. 2B), although this haplogroup is also present with lower frequencies in individ-
uals diagnosed with other rheumatic diseases, such as OA and RA (Supplementary Fig. S2). Regarding the H 
sub-haplogroups identified in the Ereño necropolis, H2 (the most frequent one, 36.7%), showed differences in the 
individuals with joint manifestations with respect to those who did not have these manifestations (Supplementary 
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Fig. S3). This result suggests that this sub-haplogroup would be strongly related to a higher risk of developing 
rheumatic diseases. Moreover, H2 was identified in 57% of the individuals diagnosed with SpA (Supplementary 
Figure S4), suggesting that sub-haplogroup H2 increases the risk of developing SpA.
The other mitochondrial haplogroups (U, T, K, R, J, HV) showed a small sample size, which does not allow 
determining their role in the susceptibility of developing rheumatic diseases (Table 1, Supplementary Fig. S1).
The proposed relationships between these mitochondrial haplogroups and their protective or non-protective 
role in different pathologies are based on the nature of the mitochondrion, in which, by means of the Oxidative 
Phosphorylation System (OXPHOS), energy is generated to produce heat and thus maintain the body tempera-
ture, as well as ROS (Reactive Oxygen Species)25,27. Different studies have suggested that European haplogroups 
would have been molded by selective mechanisms related to low temperatures during the last glacial period, when 
Homo sapiens dispersed over Europe25–27,68. In the present study, we propose that the temperature decrease that 
took place in the Little Ice Age (LIA) was an environmental factor that influenced the selection of some mitochon-
drial haplogroups over others, favouring those haplogroups that were more efficient at obtaining energy and heat 
from food to endure lower temperatures and food shortage.
Haplogroup H, one of the most energy-efficient mitochondrial lineages, has a high frequency in the medi-
eval population of this study that lived through the LIA, a period in which energy demands would have risen. 
However, this haplogroup produces a high oxidative stress, cell damage and cartilage degeneration, promoting 
the development of degenerative bone diseases24,27,69,70. In this study, we observed that the individuals who carried 
haplogroup H had a significantly high frequency of rheumatic pathologies, more specifically spondyloarthropa-
thies, which was also verified for sub-haplogroup H2.
conclusions
From the evolutionary perspective, the high frequency of haplogroup H found in the population of San Miguel 
de Ereñozar (Basque Country, Spain) could be considered as a result of a biological adaptation related to adverse 
environmental conditions, such as the ones that took place during the Little Ice Age, since this mitochondrial 
haplogroup is more energy-efficient at enduring and surviving these conditions. However, this would imply a 
biological trade-off, increasing the risk of developing rheumatic diseases.
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